Pathophysiology of insulin resistance in small for gestational age subjects: a role for adipose tissue?

Area of Science:

• Developmental biology
• Metabolic health
• Public health

Background:

• Reduced fetal growth is associated with increased risks of chronic diseases later in life, including cardiovascular diseases, hypertension, dyslipidemia, and type 2 diabetes.
• Insulin resistance is a common feature of these conditions and is believed to play a significant role in their development.

Purpose of the Study:

• To explore the pathways linking fetal development to long-term health risks.
• To examine hypotheses explaining the association between fetal growth and later-life morbidity.
• To consider the impact of early postnatal events on disease risk.

Main Methods:

• Literature review of long-term health risks associated with reduced fetal growth.
• Analysis of proposed hypotheses, including environmental factors, genetic susceptibility, and catch-up growth dynamics.
• Consideration of early postnatal events in relation to fetal growth.

Main Results:

• Established link between reduced fetal growth and increased risk of cardiovascular diseases, hypertension, dyslipidemia, and type 2 diabetes.
• Identified insulin resistance as a key factor in the pathogenesis of these conditions.
• Highlighted the difficulty in fully tracing the pathway from fetal events to later-life morbidity.

Conclusions:

• The relationship between fetal growth and long-term health is complex, involving potential interactions between fetal environment, genetics, and postnatal development.
• Further research is needed to elucidate the precise pathways linking early life events to chronic disease development.
• Considering the impact of early postnatal events is crucial for developing effective public health strategies and early interventions to mitigate lifelong disease risk.